Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023)
Avalo Therapeutics (AVTX) recorded Receivables - Net of $38,000 in Q2 2023, down 95.8% from $900,000 a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023) Analysis & Trends
At the end of FY2021, Avalo Therapeutics reported Receivables - Net of $1.06 million, down 51.3% from FY2020.
- Annual Receivables - Net has a five-year compound annual growth rate of 51.6% (FY2016 to FY2021).
- Across earlier years, Receivables - Net came in at $2.18 million in FY2020 (+117.3%), $1 million in FY2019 (+21.8%), $822,327 in FY2018 (-72.0%) and $2.94 million in FY2017.
- The Q2 2023 figure is the lowest quarterly Receivables - Net in data going back to Q4 2016.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 117.3% in Q4 2020, against a decline of 95.8% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 38,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 938,000.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 4.12 Mn |
| Mar 31, 2021 | 3.13 Mn |
| Dec 31, 2020 | 2.18 Mn |
| Sep 30, 2020 | 1.67 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.19 Mn |
| Dec 31, 2019 | 1.00 Mn |
| Sep 30, 2019 | 4.96 Mn |
| Jun 30, 2019 | 2.86 Mn |
| Mar 31, 2019 | 2.72 Mn |
| Dec 31, 2018 | 822,327.00 |
| Sep 30, 2018 | 3.01 Mn |
| Jun 30, 2018 | 3.31 Mn |
| Mar 31, 2018 | 2.83 Mn |
API Access
Avalo Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();